Latest news
Alnylam’s slump deepens; Q2 earnings roundup; and more - Endpoints NewsEndpoints News · Sat, 01 Aug 2026 10:00:00 GMTAlnylam cuts Amvuttra sales guidance as demand shifts, hurting stock - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 07:00:00 GMTAlnylam’s stock is down 30% despite a booming biotech market. Here’s why - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMT